Close Menu

NEW YORK (GenomeWeb) – Cancer diagnostics developer Metamark Genetics announced today that it has signed a coverage deal for its urological cancer diagnostics with Blue Cross and Blue Shield of Texas, effective June 1.

The agreement covers all of BCBS insured members in Texas and gives them access to Metamark's array of urology specialized diagnostics.

Specific terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

UK Royal Statistical Society is organizing a working group to develop guidelines for assessing COVID-19 tests, the Guardian reports.

The Washington Post reports that the White House chief of staff has asked the US Food and Drug Administration to justify the stricter standards it is seeking for a coronavirus vaccine.

President Donald Trump's "good genes" comment raises eugenics concerns, CNN reports.

In PLOS this week: genetic analysis of tremor condition, analysis of a West and Central African tree used in traditional medicine, and more.